0,972  0,001  AR expression inhibitor
0,941  0,005  Apoptosis agonist
0,878  0,004  Antioxidant
0,863  0,004  Antipsoriatic
0,863  0,008  Antiinflammatory
0,859  0,005  TNF expression inhibitor
0,854  0,004  Lipoprotein disorders treatment
0,834  0,003  Antineoplastic (brain cancer)
0,832  0,007  Antineoplastic (breast cancer)
0,823  0,004  Skin irritative effect
0,801  0,005  Prostate cancer treatment
0,797  0,004  Hypolipemic
0,795  0,004  UDP-glucuronosyltransferase substrate
0,794  0,007  Carcinogenic
0,783  0,006  Radioprotector
0,766  0,003  Antiacne
0,759  0,001  Alcohol dehydrogenase substrate
0,761  0,005  Caspase 3 stimulant
0,757  0,005  CYP2C19 substrate
0,752  0,004  Antineoplastic (renal cancer)
0,751  0,005  Antiosteoporotic
0,757  0,012  Antineoplastic (lung cancer)
0,735  0,001  Retinoic acid receptor agonist
0,732  0,005  Eye irritation, high
0,726  0,008  Chemoprotective
0,719  0,006  Bone diseases treatment
0,717  0,014  Embryotoxic
0,701  0,005  Antineoplastic (pancreatic cancer)
0,708  0,012  Antileukemic
0,714  0,022  Caspase 9 stimulant
0,695  0,005  Antineoplastic (glioma)
0,695  0,009  Antineoplastic (solid tumors)
0,691  0,005  Antineoplastic enhancer
0,690  0,004  Antiulcerative
0,683  0,003  Lipid peroxidase inhibitor
0,683  0,005  Free radical scavenger
0,683  0,010  Antineoplastic (ovarian cancer)
0,677  0,005  Antineoplastic (multiple myeloma)
0,676  0,004  Skin whitener
0,673  0,005  Hypoglycemic
0,670  0,005  Antineoplastic (lymphoma)
0,670  0,005  Antifungal
0,664  0,005  Apoptosis antagonist
0,643  0,010  CYP2D6 substrate
0,647  0,016  Alzheimer's disease treatment
0,649  0,020  Teratogen
0,633  0,010  UGT1A9 substrate
0,630  0,010  Immunosuppressant
0,632  0,012  Vasodilator, peripheral
0,624  0,004  Antineoplastic (squamous cell carcinoma)
0,637  0,019  GST A substrate
0,619  0,002  Electron transport complex I inhibitor
0,635  0,019  15-Lipoxygenase inhibitor
0,619  0,003  Neurotrophic factor enhancer
0,623  0,009  Antimycobacterial
0,613  0,009  Nitric oxide antagonist
0,614  0,010  NOS2 expression inhibitor
0,606  0,006  Antineoplastic (carcinoma)
0,606  0,006  Antiglaucomic
0,623  0,024  Antidiabetic
0,623  0,024  Cyclophilin D inhibitor
0,592  0,005  Myocardial infarction treatment
0,589  0,003  ABCA1 expression enhancer
0,595  0,009  Antituberculosic
0,589  0,009  Antiprotozoal (Leishmania)
0,591  0,011  Cardioprotectant
0,583  0,007  Vasodilator
0,585  0,012  Histamine release inhibitor
0,588  0,015  Mutagenic
0,576  0,003  CYP2B6 inhibitor
0,579  0,007  UGT1A1 substrate
0,570  0,007  Antineoplastic (glioblastoma multiforme)
0,545  0,001  Papain-like protease (SARS coronavirus) inhibitor
0,566  0,024  Antiparkinsonian
0,551  0,013  Antidiabetic (type 2)
0,554  0,015  Proliferative diseases treatment
0,573  0,035  Transcription factor NF kappa B inhibitor
0,549  0,013  Antiparasitic
0,541  0,008  Antihelmintic
0,531  0,001  Retinoic acid receptor antagonist
0,545  0,019  Sensitization
0,532  0,008  Antihypoxic
0,527  0,004  DNA polymerase I inhibitor
0,531  0,007  Wound healing agent
0,548  0,029  Antibacterial
0,528  0,009  Antihypertriglyceridemic
0,527  0,008  Antineoplastic (lymphocytic leukemia)
0,533  0,016  Cardiovascular analeptic
0,519  0,005  Platelet adhesion inhibitor
0,527  0,018  Hepatic disorders treatment
0,525  0,017  Chemopreventive
0,514  0,017  Lipoxygenase inhibitor
0,500  0,005  VCAM1 expression inhibitor
0,513  0,019  Cytostatic
0,516  0,024  Antihypercholesterolemic
0,519  0,028  Antipruritic, allergic
0,516  0,025  Stroke treatment
0,494  0,004  Antiinfertility, female
0,491  0,004  Antineoplastic antibiotic
0,488  0,005  UGT2B7 substrate
0,483  0,001  Retinoid X beta receptor agonist
0,504  0,023  Antineoplastic (melanoma)
0,507  0,028  Antithrombotic
0,467  0,004  Neurotrophic factor
0,460  0,001  Retinoic acid gamma receptor agonist
0,453  0,005  Growth factor agonist
0,455  0,009  Abortion inducer
0,465  0,019  ICAM1 expression inhibitor
0,470  0,028  Cytotoxic
0,472  0,034  GABA C receptor rho-3 antagonist
0,447  0,013  Antineoplastic (small cell lung cancer)
0,450  0,017  Antidiabetic symptomatic
0,476  0,043  Antiprotozoal
0,459  0,029  FMO1 substrate
0,424  0,001  Retinoic acid beta receptor agonist
0,427  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,456  0,042  Antineoplastic (colorectal cancer)
0,417  0,003  Farnesoid X receptor antagonist
0,420  0,008  Protein-tyrosine phosphatase inhibitor
0,442  0,030  Antineoplastic (cervical cancer)
0,413  0,004  LDLR expression enhancer
0,416  0,011  UGT1A3 substrate
0,409  0,004  Antihemorrhagic
0,422  0,020  Antineoplastic (liver cancer)
0,402  0,001  Retinoid X gamma receptor agonist
0,410  0,010  Genotoxic
0,433  0,041  Immunostimulant
0,442  0,050  CYP2C9 substrate
0,394  0,005  Retinopathy treatment
0,393  0,005  Gastrin inhibitor
0,427  0,045  Antineoplastic (colon cancer)
0,385  0,003  Lipase inhibitor
0,392  0,013  GST M1-1 substrate
0,379  0,002  Retinoic acid alpha receptor agonist
0,404  0,027  Antiprotozoal (Trypanosoma)
0,426  0,049  CYP2C19 inhibitor
0,431  0,055  Antiobesity
0,371  0,003  Antifungal (Candida)
0,390  0,023  Vascular (periferal) disease treatment
0,373  0,007  Glutathione S-transferase substrate
0,387  0,027  UGT1A6 substrate
0,373  0,014  Thrombolytic
0,382  0,025  Antineoplastic (osteosarcoma)
0,361  0,004  Peroxisome proliferator-activated receptor gamma agonist
0,361  0,004  TRPA1 agonist
0,357  0,003  Farnesyltransferase inhibitor
0,358  0,007  5-Lipoxygenase inhibitor
0,384  0,040  Metabolic disease treatment
0,391  0,048  5 Hydroxytryptamine release stimulant
0,340  0,001  Retinoid X gamma receptor antagonist
0,373  0,038  Antineoplastic (non-small cell lung cancer)
0,371  0,036  Huntington's disease treatment
0,371  0,038  UGT2B4 substrate
0,339  0,008  Cholesterol synthesis inhibitor
0,338  0,009  Phospholipase A2 inhibitor
0,390  0,065  CYP3A4 substrate
0,347  0,023  UGT1A4 substrate
0,335  0,014  Bone formation stimulant
0,322  0,002  Squalene synthetase inhibitor
0,354  0,035  Superoxide dismutase inhibitor
0,336  0,018  Melanin inhibitor
0,336  0,020  Antiviral (Herpes)
0,349  0,034  Acute neurologic disorders treatment
0,353  0,039  Radiosensitizer
0,311  0,003  Aldehyde dehydrogenase substrate
0,311  0,004  Coagulant
0,309  0,003  Ca(v)3.1 blocker
0,363  0,059  Cholesterol antagonist
0,326  0,023  Hepatoprotectant
0,299  0,002  Retinoic acid alpha receptor antagonist
0,373  0,078  Atherosclerosis treatment
0,347  0,052  CYP1A2 substrate
0,286  0,002  Arachidonic acid antagonist
0,320  0,037  DNA synthesis inhibitor
0,358  0,077  CYP2C9 inhibitor
0,295  0,019  Amylase inhibitor
0,281  0,005  Gastric antisecretory
0,293  0,019  Sepsis treatment
0,280  0,008  ATPase inhibitor
0,289  0,017  GST P1-1 substrate
0,273  0,005  Vanilloid agonist
0,292  0,024  Diabetic retinopathy treatment
0,320  0,056  Hypoxia-inducible factor 1 alpha inhibitor
0,298  0,034  Tyrosine 3 hydroxylase inhibitor
0,280  0,020  Protein kinase stimulant
0,335  0,077  Angiogenesis inhibitor
0,270  0,015  UGT2B9 substrate
0,318  0,064  Spasmolytic
0,271  0,019  Alpha-N-acetylglucosaminidase inhibitor
0,256  0,005  Growth stimulant
0,253  0,004  Transcription factor AP-1 inhibitor
0,284  0,035  RNA-directed DNA polymerase inhibitor
0,247  0,004  Ornithine decarboxylase inhibitor
0,242  0,002  Retinoic acid receptor gamma antagonist
0,269  0,039  DNA methyltransferase I inhibitor
0,247  0,018  Aldehyde dehydrogenase inhibitor
0,240  0,011  Microtubule formation inhibitor
0,251  0,023  Corneal wound healing stimulator
0,239  0,014  Antibacterial (Helicobacter pylori)
0,230  0,005  TRPA1 antagonist
0,257  0,032  Antieczematic atopic
0,241  0,016  UGT2B10 substrate
0,241  0,019  Antifungal enhancer
0,254  0,034  Macular degeneration treatment
0,297  0,078  Respiratory analeptic
0,233  0,015  GABA C receptor agonist
0,245  0,029  Interferon gamma antagonist
0,220  0,005  Histone deacetylase stimulant
0,220  0,005  Histone deacetylase SIRT1 stimulant
0,314  0,100  Ulceration
0,233  0,021  Uterine stimulant
0,219  0,008  Hearing loss treatment
0,229  0,021  Cell wall synthesis inhibitor
0,283  0,075  FMO3 substrate
0,270  0,063  5 Hydroxytryptamine uptake stimulant
0,244  0,042  Antiviral (West Nile virus)
0,208  0,007  Beta tubulin antagonist
0,223  0,028  Monophenol monooxygenase inhibitor
0,196  0,002  Exportin-1 inhibitor
0,235  0,041  Antipruritic, non-allergic
0,226  0,032  Succinate dehydrogenase inhibitor
0,204  0,012  Adenylate cyclase stimulant
0,213  0,023  Alkylator
0,345  0,157  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,233  0,045  Insulin sensitizer
0,192  0,005  Antiviral (Coronavirus)
0,192  0,005  Antiviral (SARS coronavirus)
0,203  0,017  Movement disorders treatment
0,206  0,021  Ferrochelatase inhibitor
0,192  0,008  CYP2A6 inhibitor
0,188  0,004  Glycine receptor agonist
0,236  0,056  DNA methylase inhibitor
0,201  0,021  Retinoprotector
0,180  0,003  Glucose-6-phosphate translocase inhibitor
0,184  0,008  CDC25A inhibitor
0,183  0,008  GST T1-1 substrate
0,180  0,007  Ca2+-transporting ATPase inhibitor
0,181  0,010  Keratolytic
0,172  0,003  Geranylgeranyltransferase I inhibitor
0,244  0,075  Platelet antagonist
0,190  0,022  Cyclooxygenase 3 inhibitor
0,265  0,097  Analeptic
0,213  0,050  Antimutagenic
0,166  0,003  Squalene epoxidase inhibitor
0,168  0,005  ATPase (Vacuolar H+) inhibitor
0,164  0,002  Retinoic acid beta receptor antagonist
0,166  0,005  Glycine receptor antagonist
0,276  0,116  Antiprotozoal (Plasmodium)
0,166  0,010  Antidote, mercury
0,244  0,088  Transcription factor STAT3 inhibitor
0,257  0,103  CTGF expression inhibitor
0,176  0,021  Pregnane X receptor agonist
0,269  0,116  Vasodilator, coronary
0,192  0,039  Tubulin antagonist
0,174  0,021  Vanilloid 1 agonist
0,192  0,039  Carcinogenic, group 1
0,157  0,005  CDC25B inhibitor
0,227  0,075  Antihypotensive
0,200  0,049  Liver fibrosis treatment
0,243  0,093  CYP1A2 inhibitor
0,194  0,048  Phospholipase C inhibitor
0,153  0,009  Phosphodiesterase 6D inhibitor
0,175  0,031  Autism spectrum disorders treatment
0,166  0,025  Gastritis treatment
0,160  0,020  Sphingomyelinase inhibitor
0,152  0,012  Antiviral (Rhinovirus)
0,249  0,110  12-Lipoxygenase inhibitor
0,160  0,023  Adenylate kinase inhibitor
0,199  0,064  5 Hydroxytryptamine 3E antagonist
0,135  0,003  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,149  0,018  Anabolic
0,147  0,016  UGT2B11 substrate
0,162  0,032  Antiviral (Poxvirus)
0,150  0,020  Actinic keratosis treatment
0,208  0,080  Antiparkinsonian, rigidity relieving
0,147  0,020  Interleukin 2 antagonist
0,141  0,014  Tourette's syndrome treatment
0,199  0,072  Non-steroidal antiinflammatory agent
0,174  0,048  GABA C receptor rho-2 antagonist
0,170  0,048  SULT1A3 substrate
0,153  0,031  Contraceptive female
0,149  0,029  Antiviral (Influenza B)
0,197  0,077  Pneumotoxic
0,148  0,029  Mediator release inhibitor
0,125  0,009  Peroxisome proliferator-activated receptor gamma antagonist
0,129  0,014  Thioredoxin reductase inhibitor
0,119  0,004  Retinoid X alpha receptor agonist
0,128  0,012  Na+ K+ transporting ATPase inhibitor
0,147  0,032  GABA C receptor antagonist
0,181  0,066  Antirickettsial
0,135  0,022  Antibiotic
0,147  0,036  Shock treatment
0,118  0,007  Phospholipase D inhibitor
0,126  0,015  Bile acid receptor antagonist
0,171  0,061  Acaricide
0,144  0,035  Photosensitizer
0,168  0,058  UGT2B15 substrate
0,112  0,003  Pregnane X receptor antagonist
0,173  0,064  Death-associated protein kinase 2 inhibitor
0,216  0,109  Flavin-containing monooxygenase substrate
0,228  0,122  NOS3 expression inhibitor
0,144  0,039  Excitatory amino acid transporter EAAC1 inhibitor
0,143  0,040  Antiviral (Papilloma)
0,126  0,023  Transcription factor NF kappa B stimulant
0,194  0,092  Age-related macular degeneration treatment
0,114  0,014  Acyl-CoA dehydrogenase inhibitor
0,162  0,062  Antidote
0,102  0,003  Kainate receptor agonist
0,104  0,005  Vanilloid 2 antagonist
0,148  0,049  Antihelmintic (Trematoda)
0,098  0,004  Geranyltranstransferase inhibitor
0,149  0,054  Cocaine dependence treatment
0,105  0,011  Peroxisome proliferator-activated receptor alpha agonist
0,173  0,080  Diabetic nephropathy treatment
0,127  0,033  DNA directed RNA polymerase inhibitor
0,098  0,005  Retinoid X receptor agonist
0,127  0,034  GABA C receptor rho-1 antagonist
0,128  0,038  Dementia treatment
0,133  0,044  MAO B inhibitor
0,149  0,061  MAO inhibitor
0,094  0,006  Anesthetic inhalation
0,121  0,034  Carcinogenic, group 2A
0,089  0,003  Retinoid X receptor antagonist
0,123  0,037  Vascular dementia treatment
0,152  0,066  Antidiabetic (type 1)
0,099  0,016  Antidote, organophosphates
0,121  0,038  Prolactin inhibitor
0,276  0,193  5 Hydroxytryptamine release inhibitor
0,181  0,099  Histone acetyltransferase inhibitor
0,084  0,006  Nicotinic acid receptor agonist
0,097  0,019  Vanilloid 4 agonist
0,124  0,047  HDL-cholesterol increasing
0,078  0,002  Retinoid X alpha receptor antagonist
0,102  0,027  Interferon agonist
0,112  0,037  Triose-phosphate isomerase inhibitor
0,097  0,022  Phosphodiesterase VI inhibitor
0,167  0,093  Systemic lupus erythematosus treatment
0,094  0,020  Antitreponemal
0,108  0,035  Topoisomerase II alpha inhibitor
0,155  0,082  Interleukin 6 antagonist
0,204  0,133  Transcription factor STAT inhibitor
0,123  0,052  Mucolytic
0,082  0,011  Histone deacetylase 7 inhibitor
0,074  0,004  Prostaglandin EP4 agonist
0,090  0,020  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,101  0,031  Phosphofructokinase-1 inhibitor
0,141  0,073  Antifungal (Cryptococcus)
0,123  0,055  Cystathionine beta-synthase inhibitor
0,114  0,047  UDP-glucose 4-epimerase inhibitor
0,071  0,004  HMG CoA reductase inhibitor
0,077  0,011  Histone deacetylase 8 inhibitor
0,118  0,052  Antihelmintic (Fasciola)
0,181  0,115  Aldehyde oxidase inhibitor
0,084  0,019  Acetyl-CoA transferase inhibitor
0,213  0,151  Antiallergic
0,077  0,015  Aconitate hydratase inhibitor
0,139  0,079  Antiprotozoal (Coccidial)
0,094  0,034  Glutamate dehydrogenase inhibitor
0,085  0,026  Endocannabinoid uptake inhibitor
0,067  0,008  Prostaglandin agonist
0,120  0,062  Antiprotozoal (Babesia)
0,109  0,051  Creatine kinase inhibitor
0,096  0,038  Porphobilinogen synthase inhibitor
0,083  0,027  Carbamoyl phosphate synthetase inhibitor
0,072  0,016  H+/K+-transporting ATPase inhibitor
0,100  0,043  Glutamate release inhibitor
0,133  0,077  Histone deacetylase SIRT1 inhibitor
0,115  0,061  SULT1A1 substrate
0,099  0,045  NADH dehydrogenase inhibitor
0,140  0,087  Acute respiratory distress syndrome (ARDS) treatment
0,073  0,021  Antimetabolite
0,137  0,085  Peroxidase inhibitor
0,081  0,030  Histone deacetylase inhibitor
0,066  0,015  Glucose-6-phosphate isomerase inhibitor
0,110  0,059  AMP-activated protein kinase stimulant
0,071  0,021  Postcoital contraceptive
0,164  0,114  Angiogenesis stimulant
0,064  0,014  Factor III inhibitor
0,087  0,038  Estrogen receptor alpha antagonist
0,059  0,010  Fumarate hydratase inhibitor
0,061  0,012  Liver X receptor alpha agonist
0,056  0,008  Peroxisome proliferator-activated receptor alpha antagonist
0,118  0,070  Antifungal (Pneumocystis)
0,086  0,039  Glutamate decarboxylase inhibitor
0,064  0,017  Aldosterone antagonist
0,077  0,031  Antiemphysemic
0,051  0,005  Prostaglandin EP2 agonist
0,155  0,109  P-glycoprotein inhibitor
0,067  0,022  Leukotriene B4 antagonist
0,158  0,114  Antimitotic
0,106  0,062  Beta glucuronidase inhibitor
0,061  0,017  Cholesterol esterase inhibitor
0,059  0,015  Histamine H2 receptor agonist
0,046  0,003  Retinoid X beta receptor antagonist
0,056  0,012  Membrane dipeptidase inhibitor
0,142  0,100  Muscular dystrophy treatment
0,071  0,028  Alcohol oxidase inhibitor
0,103  0,061  Bronchodilator
0,163  0,121  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,044  0,005  Geranylgeranyltransferase inhibitor
0,053  0,014  TRPM8 blocker
0,074  0,035  Hyperparathyroidism treatment
0,070  0,032  Biliverdin reductase inhibitor
0,080  0,042  Aminopeptidase I inhibitor
0,052  0,015  Histone deacetylase 9 inhibitor
0,043  0,005  Inosine monophosphate dehydrogenase 1 inhibitor
0,074  0,036  SULT2A1 substrate
0,065  0,028  Lipocortins synthesis agonist
0,076  0,042  Prostaglandin-E synthase inhibitor
0,046  0,013  Histone deacetylase 10 inhibitor
0,088  0,055  Granulocyte macrophage colony stimulating factor agonist
0,097  0,064  Nitric-oxide synthase inhibitor
0,065  0,032  Ribonucleoside-diphosphate reductase inhibitor
0,102  0,069  UGT2B1 substrate
0,057  0,026  Lysophosphatidic acid 3 receptor antagonist
0,065  0,034  Ribonucleotide reductase inhibitor
0,059  0,029  Thromboxane synthase inhibitor
0,070  0,039  Uterine relaxant
0,174  0,143  Nitric-oxide synthase stimulant
0,085  0,054  Inducible nitric-oxide synthase inhibitor
0,042  0,011  Cholesterol ester transfer protein antagonist
0,094  0,064  Lanosterol 14 alpha demethylase inhibitor
0,128  0,098  Hemostatic
0,045  0,015  Histone deacetylase 11 inhibitor
0,045  0,015  Histone deacetylase class IV inhibitor
0,059  0,030  Adenine nucleotide translocase inhibitor
0,084  0,055  Estrogen-related receptor beta agonist
0,101  0,073  DOPA decarboxylase inhibitor
0,091  0,064  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,059  0,031  Dihydroorotate oxidase inhibitor
0,036  0,008  Prostaglandin E2 agonist
0,094  0,067  Electrolyte absorption antagonist
0,068  0,043  Glutamate (mGluR6) antagonist
0,069  0,045  Leukotriene synthesis inhibitor
0,060  0,037  Argininosuccinate synthase inhibitor
0,064  0,040  Antimycoplasmal
0,050  0,028  Microtubule stabilization
0,034  0,012  LFA antagonist
0,092  0,071  Aminopeptidase B inhibitor
0,076  0,055  Narcotic antagonist
0,095  0,075  Expectorant
0,052  0,032  CD45 antagonist
0,039  0,019  Ceramide glucosyltransferase inhibitor
0,061  0,042  Neuraminidase inhibitor
0,092  0,073  Carcinogenic, group 2B
0,027  0,008  Isoleucine-tRNA ligase inhibitor
0,029  0,012  Lysophosphatidic acid receptor 1 agonist
0,089  0,072  MAO A inhibitor
0,079  0,062  Antispirochetal
0,195  0,178  CYP3A4 inhibitor
0,063  0,047  Leukotriene antagonist
0,024  0,009  Neuraminidase (Influenza B) inhibitor
0,071  0,056  S-adenosyl-L-methionine decarboxylase inhibitor
0,039  0,024  Vanilloid 3 antagonist
0,062  0,048  Protease 3C (Human rhinovirus) inhibitor
0,062  0,049  Transcription factor RelA inhibitor
0,052  0,039  Nicotinic alpha3beta2 receptor antagonist
0,040  0,027  Dopamine D5 agonist
0,028  0,015  Methionyl aminopeptidase 2 inhibitor
0,107  0,094  Cathepsin H inhibitor
0,060  0,048  Antiviral (Parainfluenza)
0,054  0,042  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,038  0,027  Glutamate (mGluR8) agonist
0,093  0,082  Antiprotozoal (Toxoplasma)
0,032  0,022  Methionyl aminopeptidase 1 inhibitor
0,034  0,024  Calcium-independent phospholipase A2 inhibitor
0,050  0,040  Ornithine carbamoyltransferase inhibitor
0,033  0,023  Histone deacetylase 2 inhibitor
0,017  0,007  Lysophosphatidic acid receptor 3 agonist
0,036  0,026  Inosine monophosphate dehydrogenase inhibitor
0,066  0,057  Secretase beta inhibitor
0,024  0,014  ICAM 1 antagonist
0,032  0,023  Histone deacetylase 4 inhibitor
0,026  0,017  Vanilloid 2 agonist
0,022  0,014  Kainate receptor 1 antagonist
0,097  0,089  Topoisomerase II inhibitor
0,017  0,010  Vitamin D receptor agonist
0,038  0,031  Kainate receptor antagonist
0,068  0,061  NAT1 substrate
0,096  0,091  Carcinogenic, group 3
0,021  0,017  Vitamin D receptor antagonist
0,046  0,042  Cytokine production stimulant
0,120  0,117  Thiol protease inhibitor
0,046  0,045  Protein 50S ribosomal subunit inhibitor
0,053  0,052  Leukotriene C antagonist
0,088  0,087  Estrogen receptor beta antagonist
0,058  0,058  Interferon inducer
0,121  0,121  Neuropathy treatment

